EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

ER‐Localized Deadenylase PNLDC1 Suppresses Colorectal Cancer Progression by Targeting the mRNA Decay of TUBB4B

Lexin Liu, Yuelin Guan, Yuzhou Qin, Guiping Chen, Guozhen Wang, Xiang Yan, Xue Li, Lei Sun, Wei Yu, Shi Ouyang, Zhichao Ma, Zihao Xu und 7 weitere

Exploration · 2026-10 · 6 (5)

DOI: 10.1002/exp2.70222 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Exploration, online erschienen am 21.09.2026. Verfasst von Lexin Liu und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Children's Hospital, Zhejiang University School of Medicine National Clinical Research Center for Children and Adolescents' He…. Die Arbeit nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Colorectal cancer (CRC) remains a leading cause of cancer‐related mortality, highlighting the urgent need for novel therapeutic strategies. In this study, we find that PARN‐like Domain Containing protein‐1 (PNLDC1), an endoplasmic reticulum‐localized deadenylase, lower expresses in 91 clinical CRC tissues. Using both in vitro and in vivo models, we identify PNLDC1 as a key tumor suppressor by modulating cell cycle progression in CRC. RNA‐immunoprecipitation and sequencing analyses reveal that PNLDC1 binds cell cycle‐associated mRNAs, with TUBB4B emerging as a critical target. PNLDC1 downregulates TUBB4B mRNA, whose regulated degradation is essential for PNLDC1's tumor‐suppressive function. Restoration of TUBB4B expression counteracts PNLDC1‐mediated suppression of CRC cell proliferation, underscoring its pivotal role in CRC pathogenesis. Importantly, we demonstrate that the TUBB4B inhibitor, mebendazole, effectively suppresses the enhanced proliferation in lower‐expression PNLDC1 models, including cell, mouse xenografts, and patient‐derived tumor‐like cell clusters, positioning it as a promising therapeutic agent. These findings establish PNLDC1 as a valuable biomarker and therapeutic target, paving the way for developing novel CRC treatments.

Schlagwörter

Stichwörter der Autor:innen

PNLDC1TUBB4Bcolorectal cancerdeadenylasepatient‐derived tumor cell cluster

Autor:innen und Institutionen

  • Department of Urology, Children's Hospital, Zhejiang University School of Medicine National Clinical Research Center for Children and Adolescents' Health and Diseases Hangzhou China.
  • School of Basic Medical Sciences and Forensic Medicine Hangzhou Medical College Hangzhou Zhejiang China.
  • Department of Gastrointestinal Surgery, Guangxi Medical University Cancer Hospital Guangxi Clinical Research Center for Colorectal Cancer Nanning, Guangxi Autonomous Region China.
  • Department of Gastrointestinal Surgery The First Affiliated Hospital of Zhejiang Chinese Medical University Hangzhou China.
  • Department of Big Data in Health Science School of Public Health and The Second Affiliated Hospital Zhejiang University School of Medicine Hangzhou Zhejiang China.
  • Shandong Provincial Key Laboratory of Animal Cell and Developmental Biology School of Life Sciences Shandong University Qingdao China.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Liu, L., Guan, Y., Qin, Y., Chen, G., Wang, G., Yan, X., Li, X., Sun, L., Yu, W., Ouyang, S., Ma, Z., Xu, Z., Cao, Z., Yu, F., Zhou, T., Luo, Z., Chen, X., Yan, Y., & Hu, L. (2026). ER‐Localized Deadenylase PNLDC1 Suppresses Colorectal Cancer Progression by Targeting the mRNA Decay of TUBB4B. Exploration, 6(5). https://doi.org/10.1002/exp2.70222

Vancouver

Liu L, Guan Y, Qin Y, Chen G, Wang G, Yan X, et al. ER‐Localized Deadenylase PNLDC1 Suppresses Colorectal Cancer Progression by Targeting the mRNA Decay of TUBB4B. Exploration. 2026;6(5). doi:10.1002/exp2.70222

BibTeX
@article{Liu2026,
  author = {Liu, Lexin and Guan, Yuelin and Qin, Yuzhou and Chen, Guiping and Wang, Guozhen and Yan, Xiang and Li, Xue and Sun, Lei and Yu, Wei and Ouyang, Shi and Ma, Zhichao and Xu, Zihao and Cao, Zhongkai and Yu, Fan and Zhou, Tong and Luo, Ziyou and Chen, Xiangjun and Yan, Yongbin and Hu, Lidan},
  title = {ER‐Localized Deadenylase PNLDC1 Suppresses Colorectal Cancer Progression by Targeting the mRNA Decay of TUBB4B},
  journal = {Exploration},
  year = {2026},
  volume = {6},
  number = {5},
  doi = {10.1002/exp2.70222}
}
Kostenlos starten →